 | • レポートコード：D005-05191 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の種類別市場規模（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Merck、Boehringer、Takeda、Eli Lilly、Novartis、Mitsubishi Tanabe Pharma ・地域別グローバル市場分析 2015年-2020年 ・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の南米市場（ブラジル、アルゼンチン） ・ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market has been segmented into
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
By Application, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Dipeptidyl Peptidase IV (DPP-IV) Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market.
The report offers in-depth assessment of the growth and other aspects of the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Analysis
Dipeptidyl Peptidase IV (DPP-IV) Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales, revenue and market share for each player covered in this report.
The major players covered in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors are:
AstraZeneca
Merck
Boehringer
Takeda
Eli Lilly
Novartis
Mitsubishi Tanabe Pharma
Among other players domestic and global, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, with price, sales, revenue and global market share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in 2018 and 2019.
Chapter 3, the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sitagliptin
1.2.3 Vildagliptin
1.2.4 Saxagliptin
1.2.5 Linagliptin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
1.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer
2.3.1 Boehringer Details
2.3.2 Boehringer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer SWOT Analysis
2.3.4 Boehringer Product and Services
2.3.5 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mitsubishi Tanabe Pharma
2.7.1 Mitsubishi Tanabe Pharma Details
2.7.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.7.4 Mitsubishi Tanabe Pharma Product and Services
2.7.5 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2015-2020)
11 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment by Application
11.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025)
12.2.4 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025)
12.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 9. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 12. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 15. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 16. Merck SWOT Analysis
Table 17. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 18. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 21. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 22. Boehringer SWOT Analysis
Table 23. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 24. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 27. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 28. Takeda SWOT Analysis
Table 29. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 30. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 33. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 36. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 39. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 42. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Major Business
Table 45. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 46. Mitsubishi Tanabe Pharma SWOT Analysis
Table 47. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Services
Table 48. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer (2018-2019) (K MT)
Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Regions (2015-2020)
Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 55. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries (2015-2020)
Table 56. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 58. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 59. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries (2015-2020)
Table 60. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 62. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 65. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries (2015-2020)
Table 66. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 69. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 72. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2015-2020) (K MT)
Table 73. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2015-2020)
Table 74. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 75. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2015-2020)
Table 76. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2015-2020) (K MT)
Table 77. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2015-2020)
Table 78. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Forecast by Regions (2021-2025) (K MT)
Table 79. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Forecast by Regions (2021-2025)
Table 80. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Forecast by Type (2021-2025) (K MT)
Table 81. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Forecast by Type (2021-2025)
Table 82. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Forecast by Application (2021-2025)
Table 83. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Picture
Figure 2. Global Sales Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type in 2019
Figure 3. Sitagliptin Picture
Figure 4. Vildagliptin Picture
Figure 5. Saxagliptin Picture
Figure 6. Linagliptin Picture
Figure 7. Others Picture
Figure 8. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application in 2018
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturer in 2019
Figure 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Regions in 2018
Figure 41. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
Figure 44. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020)
Figure 46. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries (2015-2020)
Figure 48. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries in 2018
Figure 49. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries in 2018
Figure 51. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries in 2019
Figure 57. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Regions 2019
Figure 65. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries in 2019
Figure 72. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries in 2019
Figure 73. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 10140 million by 2025, from USD 9302.2 million in 2019.…- インターロイキン阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Interleukin Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.3% in the forecast period of 2020 to 2025 and will expected to reach USD 28060 million by 2025, from USD 17020 million in 2019. The Interleukin In…
- mTOR阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mTOR Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mTOR Inhibitors market report…
- 酵素阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enzyme Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 152460 million by 2025, from USD 147910 million in 2019. The Enzyme Inhibitors …
- 移行阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Migration Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Migration Inhibitors mar…